NANPDB: a resource for natural products from Northern African sources F Ntie-Kang, KK Telukunta, K Döring, CV Simoben, AF A. Moumbock, ... Journal of natural products 80 (7), 2067-2076, 2017 | 128 | 2017 |
A Bioactivity Versus Ethnobotanical Survey of Medicinal Plants from Nigeria, West Africa LL Lifongo, CV Simoben, F Ntie-Kang, SB Babiaka, PN Judson Natural products and bioprospecting 4, 1-19, 2014 | 105 | 2014 |
Molecular modeling of potential anticancer agents from African medicinal plants F Ntie-Kang, JN Nwodo, A Ibezim, CV Simoben, B Karaman, VF Ngwa, ... Journal of chemical information and modeling 54 (9), 2433-2450, 2014 | 97 | 2014 |
Exploring cancer therapeutics with natural products from African medicinal plants, part II: alkaloids, terpenoids and flavonoids J N Nwodo, A Ibezim, CV Simoben, F Ntie-Kang Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 76 | 2016 |
StreptomeDB 3.0: an updated compendium of streptomycetes natural products AFA Moumbock, M Gao, A Qaseem, J Li, PA Kirchner, B Ndingkokhar, ... Nucleic acids research 49 (D1), D600-D604, 2021 | 69 | 2021 |
Strategies to Design Selective Histone Deacetylase Inhibitors J Melesina, CV Simoben, EF Bülbül, L Praetorius, D Robaa, W Sippl ChemMedChem 16, 1–25, 2021 | 68 | 2021 |
Compounds from African medicinal plants with activities against selected parasitic diseases: schistosomiasis, trypanosomiasis and leishmaniasis CV Simoben, F Ntie-Kang, SH Akone, W Sippl Natural Products and Bioprospecting 8, 151-169, 2018 | 58 | 2018 |
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing. CV Simoben, D Robaa, A Chakrabarti, K Schmidtkunz, M Marek, ... Molecules 23 (3), 566, 2018 | 46 | 2018 |
Pharmacoinformatic investigation of medicinal plants from East Africa CV Simoben, A Qaseem, AFA Moumbock, KK Telukunta, S Günther, ... Molecular informatics 39 (11), 2000163, 2020 | 38 | 2020 |
Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants F Ntie-Kang, CV Simoben, B Karaman, VF Ngwa, PN Judson, W Sippl, ... Drug design, development and therapy, 2137-2154, 2016 | 36 | 2016 |
Exploring cancer therapeutics with natural products from African medicinal plants, Part I: Xanthones, quinones, steroids, coumarins, phenolics and other classes of compounds C V Simoben, A Ibezim, F Ntie-Kang, J N Nwodo, L L Lifongo Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 35 | 2015 |
The uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy F Ntie-Kang, LL Lifongo, CV Simoben, SB Babiaka, W Sippl, LM Mbaze RSC Advances 4 (54), 28728-28755, 2014 | 35 | 2014 |
In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties PA Onguéné, CV Simoben, GW Fotso, K Andrae-Marobela, SA Khalid, ... Computational biology and chemistry 72, 136-149, 2018 | 29 | 2018 |
Synthesis, spectroscopic characterization, crystal structure, interaction with DNA, CTAB as well as evaluation of biological potency, docking and molecular dynamics studies of … M Tahir, M Sirajuddin, A Haider, S Ali, A Nadhman, C Rizzoli Journal of Molecular Structure 1178, 29-38, 2019 | 24 | 2019 |
Novel histone deacetylase inhibitors and HIV-1 latency-reversing agents identified by large-scale virtual screening DN Divsalar, CV Simoben, C Schonhofer, K Richard, W Sippl, ... Frontiers in pharmacology 11, 905, 2020 | 23 | 2020 |
The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discovery F Ntie-Kang, LL Lifongo, CV Simoben, SB Babiaka, W Sippl, LM Mbaze RSC advances 4 (67), 35348-35370, 2014 | 21 | 2014 |
Design of selective histone deacetylase inhibitors: rethinking classical pharmacophore J Melesina, L Praetorius, CV Simoben, D Robaa, W Sippl Future Medicinal Chemistry 10 (13), 1537-1540, 2018 | 19 | 2018 |
The uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classes CV Simoben, F Ntie-Kang, LL Lifongo, SB Babiaka, W Sippl, LM Mbaze RSC advances 4 (75), 40095-40110, 2014 | 17 | 2014 |
Binding Free Energy (BFE) Calculations and Quantitative Structure–Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors CV Simoben, E Ghazy, P Zeyen, S Darwish, M Schmidt, C Romier, ... Molecules 26, 2584, 2021 | 15 | 2021 |
Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis E Ghazy, T Heimburg, J Lancelot, P Zeyen, K Schmidtkunz, A Truhn, ... European Journal of Medicinal Chemistry 225, 113745, 2021 | 10 | 2021 |